HomeCLYM • NASDAQ
add
Climb Bio Inc
Previous close
$7.26
Day range
$6.83 - $7.45
Year range
$1.05 - $8.03
Market cap
328.64M USD
Avg Volume
614.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.30M | 155.47% |
Net income | -17.52M | -108.13% |
Net profit margin | — | — |
Earnings per share | -0.26 | — |
EBITDA | -19.27M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 101.08M | -33.02% |
Total assets | 167.74M | -22.77% |
Total liabilities | 7.27M | 37.00% |
Total equity | 160.48M | — |
Shares outstanding | 47.77M | — |
Price to book | 2.16 | — |
Return on assets | -27.56% | — |
Return on capital | -28.49% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -17.52M | -108.13% |
Cash from operations | -15.64M | -183.19% |
Cash from investing | 25.54M | 147.82% |
Cash from financing | -21.00K | -151.22% |
Net change in cash | 9.88M | 116.76% |
Free cash flow | -9.69M | -619.28% |
About
Founded
2018
Headquarters
Website
Employees
29
